Update on Diffuse Lung Disease in Children

Timothy J Vece1, Lisa R Young2

  • 1Section of Pulmonology, Department of Pediatrics, Baylor College of Medicine, Houston, TX.

Chest
|October 27, 2015
PubMed

Insights

Children's interstitial lung disease comprises rare, diverse lung disorders affecting gas exchange. Recent advances improve understanding, diagnosis, and treatment of these serious pediatric conditions.

Area of Science:

  • Pediatric Pulmonology
  • Rare Diseases
  • Respiratory Medicine

Background:

  • Diffuse lung diseases in children (DLD) encompass rare, heterogeneous conditions impacting pulmonary gas exchange.
  • Collectively, these DLDs contribute to substantial pediatric morbidity, mortality, and healthcare resource use.
  • Despite individual rarity, the collective impact of DLD necessitates focused research and clinical attention.

Purpose of the Study:

  • To review recent significant advancements in the understanding of pediatric diffuse lung diseases.
  • To summarize updated diagnostic approaches for children's interstitial lung disease.
  • To outline current and emerging treatment strategies for diffuse lung diseases in children.

Main Methods:

  • Comprehensive literature review of recent studies on pediatric diffuse lung diseases.
  • Analysis of genetic discoveries and their implications for DLD.
  • Evaluation of newly developed clinical practice guidelines for DLD management.

Main Results:

  • Significant progress has been made in identifying genetic underpinnings of various DLDs.
  • Clinical practice guidelines have been established, aiding standardized diagnosis and management.
  • Advances in understanding disease mechanisms are paving the way for targeted therapies.

Conclusions:

  • Recent breakthroughs enhance the comprehension of DLD pathophysiology.
  • Improved diagnostic tools and genetic insights are transforming patient care.
  • The field is evolving towards more personalized and effective treatment paradigms for children with diffuse lung diseases.